DJ Regeneron Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ inched 0.37% higher to $900.16 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.87% to 5,010.60 and the Dow Jones Industrial Average rising 0.67% to 38,239.98.
This was the stock's second consecutive day of gains.
Regeneron Pharmaceuticals Inc. closed $98.17 below its 52-week high ($998.33), which the company achieved on February 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. $(AMGN)$ rose 1.11% to $271.91, Moderna Inc. $(MRNA)$ rose 3.01% to $104.46, and Gilead Sciences Inc. $(GILD)$ rose 0.28% to $66.95.
Data source: Dow Jones Market Data, FactSet. Data compiled April 22, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 22, 2024 16:44 ET (20:44 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments